Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1988-08-19
1991-12-03
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 49, 536 23, 424408, A61K 3100, C07H 1900
Patent
active
050700782
ABSTRACT:
2',3'-Dideoxy-3'-fluoro pyrimidine nucleosides particularly 2',3'-dideoxy-3'-fluorothymidine have been found to have particularly potent activity against adenovirus infections especially those caused by adenoviruses of serotype 8. Such compounds are preferably presented in pharmaceutical formulations adapted for ophthalmic administration.
REFERENCES:
patent: 4710492 (1987-12-01), Lin et al.
patent: 4880782 (1989-11-01), Eckstein et al.
patent: 4963662 (1990-10-01), Matthes et al.
Ajmera, et al., Article, J. Med. Chem., 1984, 27, 11-14, Synthesis and Biological Activity of 5-Fluoro-2',3'-dideoxy-3fluorouridine and its 5'-Phosphate.
Baba, et al., Antimicrobial Agents and Chemotherapy, Feb. 1987, pp. 337-339, vol. 31, No. 2, Selective Inhibitory Effect of (S)-9-(3-Hydroxy-2-Phosphonylmethoxypropyl)Adenine and 2'-Nor-Cyclic GMP on Adenovirus Replication In Vitro.
Krenitsky, et al., J. Med. Chem., 1983, 26, 891-895, 3'-Amino-2',3'-dideoxyribonucleosides of Some Pyrimidines: Synthesis and Biological Activities.
Beres, et al., J. Med. Chem., 1986, 29, 494-499, Synthesis and Antitumor and Activiral Properties of 5-Alkyl-2'-deoxyuridines, 3',5'-Cyclic Monophosphates, and Neutral Cyclic Triesters.
Matthes, et al., vol. 165, No. 1, 1989, Biochemical and Biophysical Research Communications, pp. 488-495.
Van Aerschot, et al., J. Med. Chem., 1989, 32, pp. 1743-1749, 3'-Fluoro-2',3'-dideoxy-5-chlorouridine: Most Selective Anti-HIV-1 Agent among a series of New 2'-and 3'-Fluorinated 2',3'-Dideoxynucleoside Analogues.
Balzarini, et al., Molecular Pharmacology, 35:571-577, 5-Halogeno-3'-fluoro-2',3'-dideoxyuridines as Inhibitors of Human Immunodeficiency Virus (HIV): Potent and Selective Anti-HIV Activity of 3'-Fluoro-2',3'-dideoxy-5-chlorouridine.
Balzarini, et al., vol. 158, No. 2, 1989, Biochemical and Biophysical Research Communications, pp. 413-422.
Balzarini, et al., Biochemical Pharmacology, vol. 38, No. 6, 1989, pp. 869-874.
Tetrahedron, vol. 27, 2463-2472 (1971).
Journal F. Prackt. Chemie, 315, 1, 1973, 149-154.
Journal F. Prackt. Chemie, 315, 5, 1973, 895-900.
Acta Biol. Med. Germ, 23, 759-766 (1969).
European Specification 254268.
J. Med. Chem., 1984, 27, 11-14.
J. Med. Chem., 187m 30, 1270-1278.
Cell Biology & Toxicology, vol. 2, No. 4, 1986, 441-445.
J. Med. Chem., 1987, 30, 1270-1278.
Beacham, III Lowrie M.
Daluge Susan M.
Krenitsky Thomas A.
Selway John W. T.
Van Tuttle Joel
Brown Donald
Brown Johnnie R.
Burroughs Wellcome Co.
Green Hannah O.
Nielsen Lawrence A.
LandOfFree
Antiviral compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiviral compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1697098